Table 2. Clinicopathological Characteristics of 27 Patients with Ovarian Cancer.
| Parameters | Cluster A (n = 14) | Cluster B (n = 13) | p-value |
|---|---|---|---|
| Patient age | |||
| ≤60 years | 12 | 11 | 1.000 |
| >60 years | 2 | 2 | |
| Histological type | |||
| OCCC | 13 | 2 | <0.0001* |
| HGSC | 1 | 11 | |
| FIGO stage | |||
| I+II | 12 | 6 | 0.046* |
| III+IV | 2 | 7 | |
| LN metastasis (n = 26) | |||
| No metastasis | 12 | 6 | 0.090 |
| Metastasis | 2 | 6 | |
| CA125 (n = 25) | |||
| >35 U/ml | 8 | 12 | 0.039* |
| ≤35 U/ml | 5 | 0 | |
| Ascitic cytology (n = 26) | |||
| Positive | 6 | 8 | 0.267 |
| Negative | 8 | 4 | |
| Rupture | |||
| Without | 5 | 2 | 0.490 |
| Surgical | 2 | 3 | |
| Ruptured | 7 | 8 | |
| Endometriosis (n = 26) | |||
| Positive | 10 | 3 | 0.026* |
| Negative | 4 | 9 | |
| Thrombosis (n = 24) | |||
| Positive | 1 | 1 | 0.537 |
| Negative | 12 | 10 |
OCCC, ovarian clear cell carcinoma; HGSC, high-grade serous carcinoma; FIGO, International Federation of Gynecology and Obstetrics; LN, lymph node
*Significant difference